Biomarker testing to estimate under-reported heavy alcohol consumption by persons with HIV initiating ART in Uganda

AIDS and Behavior

Volumn 14, Issue 6, 2010, Pages 1265-1268

  Hahn, Judith A ^a   Bwana, Mwebesa B ^b   Javors, Martin A ^c   Martin, Jeffrey N ^a   Emenyonu, Nneka I ^d   Bangsberg, David R ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alcohol drinking; Antiretroviral therapy; Biological markers; Carbohydrate deficient transferrin; HIV; Uganda

Indexed keywords

BIOLOGICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; CARBOHYDRATE-DEFICIENT TRANSFERRIN; DRUG DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; TRANSFERRIN;

ADULT; AGED; ALCOHOLISM; ARTICLE; BLOOD; COHORT ANALYSIS; COMPARATIVE STUDY; DRINKING BEHAVIOR; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; SELF REPORT; UGANDA;

ADULT; AGED; ALCOHOL DRINKING; ALCOHOLISM; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; SELF REPORT; TRANSFERRIN; UGANDA; YOUNG ADULT;

EID: 79952279361     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9768-y     Document Type: Article

References (12)

1. Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: A systematic review and meta-analysis of African studies. Sex Transm Dis. 2007;34(11):856-63.
2. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180-202.
3. Hahn JA, Samet JH. Alcohol and HIV disease progression: weighing the evidence. Curr HIV AIDS Rep. 2010 (in press).
4. Global Status Report on Alcohol. 2004. http://www.who.int/sub stance-abuse/publications/statusreportalcoholafro/en/index.html. Accessed 4 Nov 2004.
5. Hahn JA, Maier M, Byakika-Tusiime J, Oyugi JH, Bangsberg DR. Hepatotoxicity during nevirapine-based fixed-dose combination antiretroviral therapy in kampala, Uganda. J Int Assoc Physicians AIDS Care (Chic Ill). 2007;6(2):83-6.
6. Bergstrom JP, Helander A. Clinical characteristics of carbohydrate-deficient transferrin (%disialotransferrin) measured by HPLC: Sensitivity, specificity, gender effects, and relationship with other alcohol biomarkers. Alcohol Alcohol. 2008;43(4): 436-41.
7. Golka K, Wiese A. Carbohydrate-deficient transferrin (CDT)-a biomarker for long-term alcohol consumption. J Toxicol Environ Health. 2004;7(4):319-37.
8. Helander A, Carlsson S. Carbohydrate-deficient transferrin and gamma-glutamyl transferase levels during disulfiram therapy. Alcohol Clin Exp Res. 1996;20(7):1202-5.
9. Helander A, Husa A, Jeppsson JO. Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem. 2003;49(11):1881-90.
10. Bianchi V, Ivaldi A, Raspagni A, Arfini C, Vidali M. Use of carbohydrate-deficient transferrin (CDT) and a combination of GGT and CDT (GGT-CDT) to assess heavy alcohol consumption in traffic medicine. Alcohol Alcohol. 2010;45:247-51.
11. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med. 2007; 45(8):953-61.
12. Papas RK, Sidle JE, Wamalwa ES, et al. Estimating alcohol content of traditional brew in western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav. 2010;14(4):836-44.